Actelion Ltd (ALIOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALIOF | AZN | AMGN | GILD | BMY |
| Company | Actelion Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 278.3400 | 205.26 | 384.35 | 147.20 | 61.46 |
| High | 280.0000 | 205.26 | 384.35 | 147.20 | 61.46 |
| Low | 278.3400 | 205.26 | 384.35 | 147.20 | 61.46 |
| Latest | 278.5000 | 205.26 | 384.35 | 147.20 | 61.46 |
| Change | unch | -0.53 | +0.02 | +0.08 | +0.16 |
| % Change | unch | -0.26% | +0.01% | +0.05% | +0.26% |
| Volume | 100 | 8,577 | 90,890 | 2,329 | 4,283 |
| 20-Day Average Volume | 205 | 2,512,639 | 2,881,550 | 7,389,667 | 13,231,029 |
| Previous Close | 278.5000 | 205.79 | 384.33 | 147.12 | 61.30 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 277.9430 | 198.04 | 368.16 | 148.98 | 59.46 |
| 20-Day Raw Stochastic | 62.22% | 74.38% | 93.65% | 47.06% | 91.66% |
| 20-Day Relative Strength | 50.53 | 61.56 | 65.74 | 57.89 | 65.50 |
| Weighted Alpha | +62.70 | +43.91 | +35.10 | +37.88 | +17.40 |
| Today's Opinion | N/A | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | N/A | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | 100% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.89% since 10/27/17 | -1.61% since 02/19/26 | +2.36% since 02/19/26 | -2.59% since 02/19/26 | +1.92% since 02/19/26 |
| Low | 278.3400 on 11/06/17 | 204.05 on 02/20/26 | 371.39 on 02/20/26 | 146.39 on 02/25/26 | 59.65 on 02/20/26 |
| High | 280.0000 on 11/06/17 | 209.35 on 02/24/26 | 387.49 on 02/25/26 | 153.26 on 02/20/26 | 62.12 on 02/25/26 |
| 1-Month | |||||
| %Chg | +0.67% since 10/06/17 | +8.91% since 01/26/26 | +9.91% since 01/26/26 | +6.84% since 01/26/26 | +12.56% since 01/26/26 |
| Low | 276.0300 on 10/27/17 | 183.63 on 02/03/26 | 338.07 on 01/30/26 | 137.54 on 01/27/26 | 54.21 on 01/29/26 |
| High | 280.0000 on 11/06/17 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| 3-Month | |||||
| %Chg | +0.29% since 08/04/17 | +9.98% since 11/26/25 | +11.54% since 11/26/25 | +15.44% since 11/26/25 | +24.79% since 11/26/25 |
| Low | 276.0300 on 10/27/17 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.22 on 12/02/25 |
| High | 280.0000 on 11/06/17 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| 6-Month | |||||
| %Chg | +0.67% since 05/05/17 | +28.21% since 08/26/25 | +32.73% since 08/26/25 | +28.28% since 08/26/25 | +30.18% since 08/26/25 |
| Low | 273.5000 on 06/14/17 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 285.0500 on 05/25/17 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 29,891,406 | 319,161,344 | 207,180,000 | 182,528,832 | 124,835,848 |
| Shares Outstanding, K | 107,330 | 1,550,908 | 539,068 | 1,240,680 | 2,036,474 |
| Annual Sales | 2,454,930,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 707,040,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.54 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 01/01/70 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 35.21 | 25.51 | 17.52 | 18.12 | 10.02 |